vs
Cytek Biosciences, Inc.(CTKB)与IMPINJ INC(PI)财务数据对比。点击上方公司名可切换其他公司
IMPINJ INC的季度营收约是Cytek Biosciences, Inc.的1.2倍($74.3M vs $62.1M),IMPINJ INC净利率更高(11.2% vs -70.9%,领先82.1%),Cytek Biosciences, Inc.同比增速更快(8.1% vs -0.0%),IMPINJ INC自由现金流更多($2.2M vs $-1.8M),过去两年Cytek Biosciences, Inc.的营收复合增速更高(17.7% vs -14.9%)
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化,产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域,客户遍及全球多个主要地区。
Impinj Inc.是一家美国射频识别(RFID)设备及软件提供商,成立于2000年,总部位于华盛顿州西雅图,源自加州理工学院Carver Mead与Chris Diorio的研究成果。公司主营EPC Class 1 Gen 2无源超高频RFID芯片、读写器、读写器芯片、天线,以及芯片编码、业务数据采集相关的软件应用,为各行业RFID应用提供全链路产品支持。
CTKB vs PI — 直观对比
营收规模更大
PI
是对方的1.2倍
$62.1M
营收增速更快
CTKB
高出8.2%
-0.0%
净利率更高
PI
高出82.1%
-70.9%
自由现金流更多
PI
多$4.0M
$-1.8M
两年增速更快
CTKB
近两年复合增速
-14.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $62.1M | $74.3M |
| 净利润 | $-44.1M | $8.3M |
| 毛利率 | 52.9% | 49.1% |
| 营业利润率 | -9.0% | 30.5% |
| 净利率 | -70.9% | 11.2% |
| 营收同比 | 8.1% | -0.0% |
| 净利润同比 | -557.1% | — |
| 每股收益(稀释后) | — | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CTKB
PI
| Q1 26 | — | $74.3M | ||
| Q4 25 | $62.1M | $92.8M | ||
| Q3 25 | $52.3M | $96.1M | ||
| Q2 25 | $45.6M | $97.9M | ||
| Q1 25 | $41.5M | $74.3M | ||
| Q4 24 | $57.5M | $91.6M | ||
| Q3 24 | $51.5M | $95.2M | ||
| Q2 24 | $46.6M | $102.5M |
净利润
CTKB
PI
| Q1 26 | — | $8.3M | ||
| Q4 25 | $-44.1M | $-1.1M | ||
| Q3 25 | $-5.5M | $-12.8M | ||
| Q2 25 | $-5.6M | $11.6M | ||
| Q1 25 | $-11.4M | $-8.5M | ||
| Q4 24 | $9.6M | $-2.7M | ||
| Q3 24 | $941.0K | $221.0K | ||
| Q2 24 | $-10.4M | $10.0M |
毛利率
CTKB
PI
| Q1 26 | — | 49.1% | ||
| Q4 25 | 52.9% | 51.8% | ||
| Q3 25 | 52.7% | 50.3% | ||
| Q2 25 | 52.3% | 57.8% | ||
| Q1 25 | 48.6% | 49.4% | ||
| Q4 24 | 58.5% | 50.5% | ||
| Q3 24 | 56.3% | 50.0% | ||
| Q2 24 | 54.6% | 56.1% |
营业利润率
CTKB
PI
| Q1 26 | — | 30.5% | ||
| Q4 25 | -9.0% | -2.9% | ||
| Q3 25 | -17.6% | 0.7% | ||
| Q2 25 | -23.3% | 11.1% | ||
| Q1 25 | -36.1% | -12.9% | ||
| Q4 24 | 5.2% | -3.9% | ||
| Q3 24 | -8.2% | -0.8% | ||
| Q2 24 | -18.3% | 8.8% |
净利率
CTKB
PI
| Q1 26 | — | 11.2% | ||
| Q4 25 | -70.9% | -1.2% | ||
| Q3 25 | -10.5% | -13.3% | ||
| Q2 25 | -12.2% | 11.8% | ||
| Q1 25 | -27.5% | -11.4% | ||
| Q4 24 | 16.8% | -2.9% | ||
| Q3 24 | 1.8% | 0.2% | ||
| Q2 24 | -22.4% | 9.7% |
每股收益(稀释后)
CTKB
PI
| Q1 26 | — | $0.14 | ||
| Q4 25 | — | $-0.02 | ||
| Q3 25 | — | $-0.44 | ||
| Q2 25 | — | $0.39 | ||
| Q1 25 | — | $-0.30 | ||
| Q4 24 | — | $-0.06 | ||
| Q3 24 | — | $0.01 | ||
| Q2 24 | — | $0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $131.8M |
| 总债务越低越好 | — | $241.5M |
| 股东权益账面价值 | $341.7M | — |
| 总资产 | $461.5M | $502.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CTKB
PI
| Q1 26 | — | $131.8M | ||
| Q4 25 | $90.9M | $175.3M | ||
| Q3 25 | $93.3M | $190.1M | ||
| Q2 25 | $75.5M | $193.2M | ||
| Q1 25 | $95.3M | $147.9M | ||
| Q4 24 | $98.7M | $164.7M | ||
| Q3 24 | $162.3M | $170.3M | ||
| Q2 24 | $177.9M | $220.2M |
总债务
CTKB
PI
| Q1 26 | — | $241.5M | ||
| Q4 25 | — | $280.9M | ||
| Q3 25 | — | $280.4M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $283.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益
CTKB
PI
| Q1 26 | — | — | ||
| Q4 25 | $341.7M | $209.2M | ||
| Q3 25 | $378.6M | $195.0M | ||
| Q2 25 | $377.6M | $187.7M | ||
| Q1 25 | $379.6M | $160.6M | ||
| Q4 24 | $395.7M | $149.9M | ||
| Q3 24 | $385.5M | $136.1M | ||
| Q2 24 | $389.1M | $117.0M |
总资产
CTKB
PI
| Q1 26 | — | $502.5M | ||
| Q4 25 | $461.5M | $545.2M | ||
| Q3 25 | $494.9M | $516.5M | ||
| Q2 25 | $493.3M | $508.8M | ||
| Q1 25 | $482.6M | $479.8M | ||
| Q4 24 | $499.5M | $489.1M | ||
| Q3 24 | $491.2M | $476.4M | ||
| Q2 24 | $483.7M | $446.1M |
负债/权益比
CTKB
PI
| Q1 26 | — | — | ||
| Q4 25 | — | 1.34× | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.89× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-771.0K | — |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $2.2M |
| 自由现金流率自由现金流/营收 | -2.9% | 3.0% |
| 资本支出强度资本支出/营收 | 1.6% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $61.1M |
8季度趋势,按日历期对齐
经营现金流
CTKB
PI
| Q1 26 | — | — | ||
| Q4 25 | $-771.0K | $15.1M | ||
| Q3 25 | $-3.9M | $20.9M | ||
| Q2 25 | $108.0K | $33.9M | ||
| Q1 25 | $-125.0K | $-11.1M | ||
| Q4 24 | $2.0M | $12.6M | ||
| Q3 24 | $13.2M | $10.1M | ||
| Q2 24 | $6.2M | $45.5M |
自由现金流
CTKB
PI
| Q1 26 | — | $2.2M | ||
| Q4 25 | $-1.8M | $13.6M | ||
| Q3 25 | $-4.6M | $18.0M | ||
| Q2 25 | $-1.5M | $27.3M | ||
| Q1 25 | $-974.0K | $-13.0M | ||
| Q4 24 | $1.1M | $8.5M | ||
| Q3 24 | $12.2M | $4.7M | ||
| Q2 24 | $5.2M | $44.1M |
自由现金流率
CTKB
PI
| Q1 26 | — | 3.0% | ||
| Q4 25 | -2.9% | 14.7% | ||
| Q3 25 | -8.7% | 18.7% | ||
| Q2 25 | -3.2% | 27.9% | ||
| Q1 25 | -2.3% | -17.5% | ||
| Q4 24 | 1.9% | 9.3% | ||
| Q3 24 | 23.7% | 4.9% | ||
| Q2 24 | 11.0% | 43.0% |
资本支出强度
CTKB
PI
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | 1.6% | ||
| Q3 25 | 1.3% | 3.1% | ||
| Q2 25 | 3.5% | 6.7% | ||
| Q1 25 | 2.0% | 2.5% | ||
| Q4 24 | 1.6% | 4.5% | ||
| Q3 24 | 2.0% | 5.7% | ||
| Q2 24 | 2.3% | 1.3% |
现金转化率
CTKB
PI
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 2.93× | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | 45.56× | ||
| Q2 24 | — | 4.56× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
PI
暂无分部数据